Destabilization of coxsackievirus B3 genome integrated with enhanced green fluorescent protein gene

Intervirology

Volumn 54, Issue 5, 2011, Pages 268-275

  Tong, Lei ^a   Lin, Lexun ^a   Zhao, Wenran ^a   Wang, Bo ^a   Wu, Shuaiqin ^a   Liu, Huimin ^a   Zhong, Xiaoyan ^a   Cui, Yuqiong ^a   Gu, Hongxia ^a   Zhang, Fengmin ^a   Zhong, Zhaohua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Coxsackievirus B3; Enhanced green fluorescent protein; Genome destabilization

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN;

ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE SEQUENCE; GENOMIC INSTABILITY; HELA CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VIRUS GENE; VIRUS GENOME; VIRUS MUTATION; VIRUS PLAQUE; VIRUS RECOMBINANT;

ENTEROVIRUS B, HUMAN; GENOME, VIRAL; GENOMIC INSTABILITY; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; MICROBIAL VIABILITY; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE DELETION; SERIAL PASSAGE;

COXSACKIEVIRUS; HUMAN ENTEROVIRUS B;

EID: 84860389677     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000321351     Document Type: Article

References (22)

1. Racaniello VR: Picornaviridae: The virus and their replication; in Knipe DM, Howley PM, Griffin DE, Lamb RA, Straus SE, Martin MA, Roizman B (eds): Fields Virology, ed 5. Philadelphia, Lippincott Williams & Wilkins, 2007, pp 795-838.
2. Gan W, LaCelle M, Rhoads RE: Functional characterization of the internal ribosome entry site of eIF4G mRNA. J Biol Chem 1998; 273: 5006-5012.
3. Jang SK, Kräusslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E: A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 1988; 62: 2636-2643.
4. Knowlton KU: CVB infection and mechanisms of viral cardiomyopathy. Curr Top Microbiol Immunol 2008; 323: 315-335.
5. Whitton JL, Cornell CT, Feuer R: Host and virus determinants of picornavirus pathogenesis and tropism. Nat Rev Microbiol 2005; 3: 765-776.
6. Yajima T, Knowlton KU: Viral myocarditis: From the perspective of the virus. Circulation 2009; 119: 2615-2624.
7. Bowles NE, Richardson PJ, Olsen EG, Archard LC: Detection of coxsackie-B- virusspecific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986; 1: 1120-1123.
8. Bledsoe AW, Jackson CA, McPherson S, Morrow CD: Cytokine production in motor neurons by poliovirus replicon vector gene delivery. Nat Biotechnol 2000; 18: 964-969.
9. Kung SH, Wang YC, Lin CH, Kuo RL, Liu WT: Rapid diagnosis and quantification of herpes simplex virus with a green fluorescent protein reporter system. J Virol Methods 2000; 90: 205-212.
10. Jackson CA, Messinger J, Peduzzi JD, Ansardi DC, Morrow CD: Enhanced functional recovery from spinal cord injury following intrathecal or intramuscular administration of poliovirus replicons encoding IL-10. Virology 2005; 336: 173-183.
11. Heim R, Prasher DC, Tsien RY: Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci USA 1994; 91: 12501-12504.
12. Cubitt AB, Heim R, Adams SR, Boyd AE, Gross LA, Tsien RY: Understanding, improving and using green fluorescent proteins. Trends Biochem Sci 1995; 20: 448-455.
13. Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL: Cell cycle status affect coxsackievirus replication, persistence and reactivation in vitro. J Virol 2002; 76: 4430-4440.
14. Lim BK, Shin JO, Lee SC, Kim DK, Choi DJ, Choe SC, Knowlton KU, Jeon ES: Long-term cardiac gene expression using a coxsackieviral vector. J Mol Cell Cardiol 2005; 38: 745-751.
15. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S: A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 1996; 70: 7811-7818.
16. Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL: Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J Virol 2001; 75: 2377-2387.
17. Mueller S, Wimmer E: Expression of foreign proteins by poliovirus polyprotein fusion: Analysis of genetic stability reveals rapid deletions and formation of cardiovirus like open reading frames. J Virol 1998; 72: 20-31.
18. Zhong Z, Li X, Zhao W, Tong L, Liu J, Wu S, Lin L, Zhang Z, Tian Y, Zhang F: Mutations at nucleotides 573 and 579 within 5' - untranslated region augment the virulence of coxsackievirus B1. Virus Res 2008; 135: 255-259.
19. Höfling K, Tracy S, Chapman N, Kim KS, Smith Leser J: Expression of an antigenic adenovirus epitope in a group B coxsackievirus. J Virol 2000; 74: 4570-4578.
20. Kirkegaard K, Baltimore D: The mechanism of RNA recombination in poliovirus. Cell 1986; 47: 433-443.
21. Duggal R, Cuconati A, Gromeier M, Wimmer E: Genetic recombination of poliovirus in a cell-free system. Proc Natl Acad Sci USA 1997; 94: 13786-13791.
22. Johansen LK, Morrow CD: Inherent instability of poliovirus genomes containing two internal ribosome entry site (IRES) elements supports a role for the IRES in encapsidation. J Virol 2000; 74: 8335-8342